MMV

MMV - Anti-Malarial Drug Development




MMV and its partner Novartis have recently launched a sweet, paediatric anti-malarial formulation.


| 1 | 2 | 3 | 4 | 5 |


Send an Enquiry to this Company


The details you provide will not be used to send unsolicited emails.
For further information please read our Privacy Policy.




Home
New On This Site
Solutions and Services
Company A-Z
Thought Leadership
Feature Articles
White Papers
News & Updates
Gallery
Events Listings
Newsletter
Advertise With Us
Our Products
Client Logon


RSS What is RSS